Fingerprint
Dive into the research topics of 'Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: A phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: A phase 2 study
Stephen M. Ansell, Hui Tang, Paul J. Kurtin, Patricia A. Koenig, David J. Inwards, Keith Shah, Steven C. Ziesmer, Andrew L. Feldman, Radha Rao, Mamta Gupta, Charles Erlichman, Thomas E. Witzig
Research output: Contribution to journal › Article › peer-review
133
Scopus
citations